Logos Global Management LP Trevi Therapeutics, Inc. Transaction History
Logos Global Management LP
- $1.07 Billion
- Q2 2024
A detailed history of Logos Global Management LP transactions in Trevi Therapeutics, Inc. stock. As of the latest transaction made, Logos Global Management LP holds 2,800,000 shares of TRVI stock, worth $8.82 Million. This represents 0.78% of its overall portfolio holdings.
Number of Shares
2,800,000
Previous 2,800,000
-0.0%
Holding current value
$8.82 Million
Previous $8.34 Million
-0.0%
% of portfolio
0.78%
Previous 0.78%
Shares
2 transactions
Others Institutions Holding TRVI
# of Institutions
81Shares Held
54.5MCall Options Held
15.6KPut Options Held
0-
Nea Management Company, LLC Timonium, MD11.4MShares$35.8 Million3.2% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA7.38MShares$23.3 Million1.3% of portfolio
-
Rubric Capital Management LP New York, NY5.03MShares$15.8 Million0.44% of portfolio
-
Viking Global Investors LP4.4MShares$13.9 Million0.05% of portfolio
-
Vr Adviser, LLC New York, NY3.42MShares$10.8 Million1.12% of portfolio
About Trevi Therapeutics, Inc.
- Ticker TRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,322,500
- Market Cap $184M
- Description
- Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...